J Korean Pediatr Soc.  1982 Jul;25(7):717-722.

Clinical Observations and Therapeutic Effect of Rifampin in Shigellosis

Affiliations
  • 1Department of Pediatrics, Keimyung University Medical College and Hospital, Daegu, Korea.

Abstract

This paper presents the clinical, bacteriological assement and therapeutic effect of antimicrobial agents on 106 cases of shigellosis in children who had been treated at pediatric department of Keimyung University Medical College and Hospital during the period from January 1978 through June 1980. Following results were obtained 1) 68 cases(86.8%) were between 6 months to 5 years of age. 2) Male to female ratio was 9.9:1 with male predominance. 3) The cardinal clinical symptoms were diarrhea(101 cases, 95.27%) and high fever 63cases, 59.43%). The convulsions were noted in 24 cases(22.64%). 4) Shigella flexneri was most prevalent, isolated in 97 cases(91.5%) Sh. Sonnei were isolated in 8 cases(7.6%) and Sh. Dysenteriae in 1 cases(0.9%) 5) 32 cases were treated with Rifampin, 29 cases with Tobramycin, 32 cases with TMP/SMX and observed these effects clinically and bacteriologically. Rifampin was the most effective agent for shigella infections based on the following data of our study. Average duration of clinical improvement(days) : 1) Rifampin, 3.2 2) Tobramycin, 5.9 3) TMP/SMX, 5.3 Average duration of negative conversion of bacteria(days) : 1) Rifampin, 4.7 2) Tobramycin, 5.3 3) TMP/SMX, 7.0 Duration of hospitalization(days) : 1) Rifampin, 6.9 2) Tobramycin, 9.1 3) TMP/SMX, 8.3 Effectiveness(%) : 1) Rifampin, 96.9 2) Tobramycin, 72.4 3) TMP/SMX, 81.2

Keyword

Shigellosis; clinical observation; therapeutic effect; antimicrobials

MeSH Terms

Anti-Infective Agents
Child
Dysentery, Bacillary*
Female
Fever
Humans
Male
Rifampin*
Seizures
Shigella
Shigella flexneri
Tobramycin
Anti-Infective Agents
Rifampin
Tobramycin
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr